Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NPCE market cap is 305.94M. The company's latest EPS is USD -1.1041 and P/E is -9.27.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 16.51M | 16.43M | 18.01M | 18.12M | 19.26M |
| Operating Income | -7.85M | -5.95M | -5.05M | -7.55M | -6.23M |
| Net Income | -9.12M | -7.26M | -6.2M | -8.93M | -7.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 36.97M | 41.14M | 45.18M | 45.52M | 65.42M |
| Operating Income | -22.03M | -13.05M | -23.74M | -40.79M | -27.17M |
| Net Income | -29.97M | -24.28M | -36.08M | -47.08M | -32.96M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 102.23M | 99.3M | 107.65M | 98.85M | 94.39M |
| Total Liabilities | 81.01M | 82.94M | 87M | 84.51M | 84.5M |
| Total Equity | 21.23M | 16.36M | 20.65M | 14.34M | 9.89M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 21.1M | 55.95M | 133.56M | 114.11M | 107.65M |
| Total Liabilities | 76.88M | 62.36M | 60.06M | 79.33M | 87M |
| Total Equity | -129.35M | -147.83M | 73.5M | 34.78M | 20.65M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -14.06M | -16.36M | -19.7M | -7.53M | -11.43M |
| Investing | 15.37M | 19.56M | 23.03M | 2.4M | 5.63M |
| Financing | -60k | -87k | 8.13M | 72k | 581k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -25.03M | -21.61M | -24.58M | -36.87M | -19.7M |
| Investing | 3.62M | -10.77M | -85.4M | 23.8M | 23.03M |
| Financing | 21.37M | 55.01M | 102.53M | 490k | 8.13M |
| Market Cap | 305.94M |
| Price to Earnings Ratio | -9.27 |
| Price to Sales Ratio | 4.67 |
| Price to Cash Ratio | 16.93 |
| Price to Book Ratio | 14.8 |
| Dividend Yield | - |
| Shares Outstanding | 29.85M |
| Average Volume (1 week) | 72.86k |
| Average Volume (1 Month) | 92.66k |
| 52 Week Change | 14.78% |
| 52 Week High | 18.15 |
| 52 Week Low | 5.45 |
| Spread (Intraday) | 0.75 (7.32%) |
| Company Name | Neuropace Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.neuropace.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
